Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Evaluation of Characteristics and Outcomes of Patients with Primary and Secondary Plasma Cell Leukemia Treated with Modern Therapies

Megan Broughton, Subodh Bhatta, Nidhi Sharma, Elvira Umyarova, Abdullah Mohammad Khan, Srinivas Devarakonda, Naresh Bumma, Ashley Rosko, Don Benson, Francesca Cottini

Blood (2024) 144 (Supplement 1): 6980.

https://doi.org/10.1182/blood-2024-206283

Published: 2024

Journal Articles

Building Inroads for Transplant Access: Bridging the Gap for Underserved Patients with Multiple Myeloma

Srinivas Devarakonda, Qiuhong Zhao, Don Benson, Francesca Cottini, Abdullah Mohammad Khan, Elvira Umyarova, Naresh Bumma, Nowshin Islam, Nidhi Sharma, Jessica Krok-Schoen, James L Fisher, Jesse J Plascak, Electra D Paskett, Ashley Rosko

Blood (2024) 144 (Supplement 1): 7865.

https://doi.org/10.1182/blood-2024-211200

Published: 2024

Journal Articles

Second Primary Hematological Malignancy in Multiple Myeloma Patients Exposed to Lenalidomide and Autologous Stem Cell Transplantation

Justin Jiang, Joshua Galloway, Andrew Srisuwananukorn, Uma Borate, Nidhi Sharma, Naresh Bumma, Srinivas Devarakonda, Elvira Umyarova, Ashley Rosko, Abdullah Mohammad Khan, Don Benson, Francesca Cottini

Blood (2024) 144 (Supplement 1): 6954.

https://doi.org/10.1182/blood-2024-198754

Published: 2024

Journal Articles

Comparison of Long-Term Outcomes Among Patients with Chronic Myeloid Leukemia Who Undergo Initial Tyrosine Kinase Inhibitor Dose Reduction Versus Tyrosine Kinase Inhibitor Switch

Melanie T Rebechi, Quihong Zhao, Michael Marcucci, Nidhi Sharma, Allyson Waller, Marvellous Olowookere, Alyssa Swank, Christian Hu, Alice Mims, Jennifer E. Vaughn

Blood (2024) 144 (Supplement 1): 1771.

https://doi.org/10.1182/blood-2024-203869

Published: 2024

Journal Articles

Cytomegalovirus Reactivation in Patients with Multiple Myeloma Treated with Teclistamab: Risk Factors and Clinical Impact

Charles Pei, Lisa Blackburn, Nidhi Sharma, Naresh Bumma, Abdullah Mohammad Khan, Srinivas Devarakonda, Elvira Umyarova, Don Benson, Ashley Rosko, Zeinab El Boghdadly, Francesca Cottini

Blood (2024) 144 (Supplement 1): 4717.

https://doi.org/10.1182/blood-2024-201519

Published: 2024

Journal Articles

Understanding Valuation of Tyrosine Kinase Inhibitors Among Patients with Chronic Myeloid Leukemia Using a Novel Hypothetical Purchasing Task

Jennifer E. Vaughn, Quihong Zhao, Michael Marcucci, Nidhi Sharma, Alice Mims, Allyson Waller, Jeff Stein

Blood (2024) 144 (Supplement 1): 5049.

https://doi.org/10.1182/blood-2024-203641

Published: 2024

Journal Articles

Deletion 1p at Time of Diagnosis of Multiple Myeloma Portends Inferior Outcomes

Arti Vaishnav, Abdullah Khan, Qiuhong Zhao, Naresh Bumma, Francesca Cottini, Elvira Umyarova, Nidhi Sharma, Ashley E Rosko, Don Benson, Srinivas Devarakonda

Blood (2023) 142 (Supplement 1): 1974.

https://doi.org/10.1182/blood-2023-182845

Published: 2023

Journal Articles

Predictive Score for Utilization of Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Arti Vaishnav, Abdullah Khan, Qiuhong Zhao, Naresh Bumma, Francesca Cottini, Elvira Umyarova, Nidhi Sharma, Yvonne Efebera, Lynn O'Donnell, Ashley E Rosko, Sumithira Vasu, Marcos de Lima, Don Benson, Srinivas Devarakonda

Blood (2023) 142 (Supplement 1): 911.

https://doi.org/10.1182/blood-2023-184904

Published: 2023

Journal Articles

Multiple Myeloma Transplant: Examining the Intersection of Access, Age and Race

Ashley E. Rosko, Kaitlyn Dvorak, Qiuhong Zhao, Electra Paskett, Samantha Jaglowski, James L. Fisher, Jessica Krok-Schoen, Francesca Cottini, Abdullah Khan, Srinivas Devarakonda, Naresh Bumma, Elvira Umyarova, Nidhi Sharma, Don M. Benson, Jr., Jesse Plascak

Blood (2022) 140 (Supplement 1): 5170–5171.

https://doi.org/10.1182/blood-2022-164653

Published: 2022

Journal Articles

T-Cell Senescence and Exhaustion Are Associated with Interval Progression of Multiple Myeloma before Autologous Hematopoietic Cell Transplant

Alicia Bao, Ruchi Kudalkar, Jose Rodriguez, Qiuhong Zhao, Nidhi Sharma, Naresh Bumma, Srinivas Devarakonda, Abdullah Khan, Ashley E. Rosko, Elvira Umyarova, Don M. Benson, Jr., Francesca Cottini

Blood (2022) 140 (Supplement 1): 7257–7258.

https://doi.org/10.1182/blood-2022-167226

Published: 2022

Journal Articles

A Phase I Clinical Trial of Point-of-Care Manufactured Fresh Anti-CD19/20/22 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Lymphoid Malignancies (Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, B Prolymphocytic Leukemia)

Sumithira Vasu, Lapo Alinari, Nicole Szuminski, Dina Schneider, Nathan Denlinger, Wing Keung Chan, Khalid Parris, Nidhi Sharma, Hillary Bradbury, Beth Daneault, Lynn O'Donnell, Boro Dropulic, Marcos J.G. de Lima

Blood (2022) 140 (Supplement 1): 7474–7475.

https://doi.org/10.1182/blood-2022-167340

Published: 2022

Journal Articles

CD56 Has a Critical Role in Regulating Multiple Myeloma Cell Growth and Response to Therapies

Francesca Cottini, Jose Rodriguez, Maxwell Birmingham, Tiffany Hughes, Nidhi Sharma, Gerard Lozanski, Bei Liu, Yiping Yang, Emanuele Cocucci, Don M Benson, Jr.

Blood (2021) 138 (Supplement 1): 889.

https://doi.org/10.1182/blood-2021-146370

Published: 2021

Journal Articles

Interval Progression Serves As a Predictor of Adverse Outcomes in Patients with Multiple Myeloma

Alicia Bao, Qiuhong Zhao, Nidhi Sharma, Naresh Bumma, Srinivas Devarakonda, Abdullah Khan, Ashley E. Rosko, Don M Benson, Jr., Francesca Cottini

Blood (2021) 138 (Supplement 1): 3940.

https://doi.org/10.1182/blood-2021-147835

Published: 2021

Journal Articles

Utilizing Organ-Sparing Marrow Irradiation to Condition Patients Prior to Allogeneic Hematopoietic Cell Transplant with High-Risk Hematologic Malignancies: Results of a Pilot Study

Sumithira Vasu, Meghan Kromer, Qiuhong Zhao, Hannah Choe, Karilyn Larkin, Sarah A Wall, Samantha Jaglowski, Sam Penza, Jonathan E Brammer, Nidhi Sharma, Naduparambil Jacob, Marcos J.G. de Lima, Meng Welliver

Blood (2021) 138 (Supplement 1): 2856.

https://doi.org/10.1182/blood-2021-150948

Published: 2021

Journal Articles

A Phase I Clinical Trial Testing the Safety of IL-21-Expanded, Universally Alloreactive Donor-Derived Natural Killer Cells for Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

Sumithira Vasu, Nidhi Sharma, Alison R. Walker, Sarah A Wall, James S. Blachly, Greg K. Behbehani, Hannah Choe, Aarohi Thakkar, Robin Nakkula, Ella Troy, Nicole Szuminski, Marcos J.G. de Lima, Lynn O'Donnell, Dean Anthony Lee

Blood (2021) 138 (Supplement 1): 1732.

https://doi.org/10.1182/blood-2021-150750

Published: 2021

Journal Articles

Effect of Age on Outcomes of Allogeneic Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

Blood (2021) 138 (Supplement 1): 3933.

https://doi.org/10.1182/blood-2021-146334

Published: 2021

Journal Articles

Early Versus Late Discontinuation of Maintenance Therapy in Multiple Myeloma

Jordan Nunnelee, Muhammad Salman Faisal, Qiuhong Zhao, Francesca Cottini, Patrick Elder, Ashley E. Rosko, Maria Chaudhry, Abdullah Khan, Srinivas Devarakonda, Naresh Bumma, Don M Benson, Jr., Yvonne A. Efebera, Nidhi Sharma

Blood (2021) 138 (Supplement 1): 3796.

https://doi.org/10.1182/blood-2021-146698

Published: 2021

Journal Articles

Impact of Chronic Graft-Versus-Host Disease on Non-Relapse Mortality

Blood (2020) 136 (Supplement 1): 42.

https://doi.org/10.1182/blood-2020-138755

Published: 2020

Journal Articles

Improvement in Survival of AML and MDS Patients Following Allogeneic Transplant: A Long-Term Institutional Experience

Blood (2020) 136 (Supplement 1): 30.

https://doi.org/10.1182/blood-2020-139933

Published: 2020

Journal Articles

Comparison of Patient Outcomes with Two Different Formulations of Melphalan As Conditioning Chemotherapy for Autologous Stem Cell Transplantation in Multiple Myeloma

Filiz Yucebay, PharmD, BCPS, BCOP, Ashleigh Keiter, MS, Qiuhong Zhao, MS, Alison Neal, Nita Williams, Nidhi Sharma, PhD, Francesca Cottini, MD, Maria Chaudhry, MD, Ashley Rosko, MD, Don M. Benson, Jr., MD PhD, Yvonne A. Efebera, MD MPH, Naresh Bumma, MD, Abdullah Khan, MBBS, MSc, Srinivas Devarakonda, MD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-141105

Published: 2020

NARROW

Evaluation of Characteristics and Outcomes of Patients with Primary and Secondary Plasma Cell Leukemia Treated with Modern Therapies

Building Inroads for Transplant Access: Bridging the Gap for Underserved Patients with Multiple Myeloma

Second Primary Hematological Malignancy in Multiple Myeloma Patients Exposed to Lenalidomide and Autologous Stem Cell Transplantation

Comparison of Long-Term Outcomes Among Patients with Chronic Myeloid Leukemia Who Undergo Initial Tyrosine Kinase Inhibitor Dose Reduction Versus Tyrosine Kinase Inhibitor Switch

Cytomegalovirus Reactivation in Patients with Multiple Myeloma Treated with Teclistamab: Risk Factors and Clinical Impact

Understanding Valuation of Tyrosine Kinase Inhibitors Among Patients with Chronic Myeloid Leukemia Using a Novel Hypothetical Purchasing Task

Deletion 1p at Time of Diagnosis of Multiple Myeloma Portends Inferior Outcomes

Predictive Score for Utilization of Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Multiple Myeloma Transplant: Examining the Intersection of Access, Age and Race

T-Cell Senescence and Exhaustion Are Associated with Interval Progression of Multiple Myeloma before Autologous Hematopoietic Cell Transplant

A Phase I Clinical Trial of Point-of-Care Manufactured Fresh Anti-CD19/20/22 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Lymphoid Malignancies (Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, B Prolymphocytic Leukemia)

CD56 Has a Critical Role in Regulating Multiple Myeloma Cell Growth and Response to Therapies

Interval Progression Serves As a Predictor of Adverse Outcomes in Patients with Multiple Myeloma

Utilizing Organ-Sparing Marrow Irradiation to Condition Patients Prior to Allogeneic Hematopoietic Cell Transplant with High-Risk Hematologic Malignancies: Results of a Pilot Study

A Phase I Clinical Trial Testing the Safety of IL-21-Expanded, Universally Alloreactive Donor-Derived Natural Killer Cells for Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

Effect of Age on Outcomes of Allogeneic Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

Early Versus Late Discontinuation of Maintenance Therapy in Multiple Myeloma

Impact of Chronic Graft-Versus-Host Disease on Non-Relapse Mortality

Improvement in Survival of AML and MDS Patients Following Allogeneic Transplant: A Long-Term Institutional Experience

Comparison of Patient Outcomes with Two Different Formulations of Melphalan As Conditioning Chemotherapy for Autologous Stem Cell Transplantation in Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only